drugset
drugset / Trial / NCT01533870

Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118

NCT01533870 ↗

Phase 1 Completed 22 enrolled AstraZeneca
Non-randomizedCrossoverOpen-labelBasic science

Summary

Study in healthy volunteers to investigate the effects of Rifampin on the Pharmacokinetics of NKTR-118.

Timeline

Start
2012-03
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxegol Small molecule 25 mg Oral
Comparator Rifampin Small molecule 600 mg Oral

Indications

constipation disorder